- Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils. Nagano, C., Azuma, A., Ishiyama, H., Sekiguchi, K., Imagawa, K., Kikuchi, M. J. Pharmacol. Exp. Ther. (2001)